{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
SINTX Technologies, Inc.
SINTX Technologies Hits 52-Week Low as Stock Plummets to $1.56
SINTX Technologies, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant stock price decline. The company has reported consecutive quarterly losses, low sales figures, and negative financial metrics, while institutional investor participation has also decreased, indicating a tough market environment.
SINTX Technologies Hits New 52-Week Low at $1.66 Amid Ongoing Struggles
SINTX Technologies, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant stock price decline. The company has reported losses for five consecutive quarters, with declining sales and negative financial metrics, leading to increased perceptions of risk among investors.
SINTX Technologies Hits New 52-Week Low at $1.85 Amid Ongoing Struggles
SINTX Technologies, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant stock price decline. The company has reported consecutive quarterly losses, declining net sales, and negative financial metrics, while institutional investor participation has also decreased, highlighting ongoing difficulties in its financial performance.
SINTX Technologies Hits New 52-Week Low at $1.96 Amid Ongoing Struggles
SINTX Technologies, Inc. has reached a new 52-week low, reflecting a significant decline in stock performance over the past year. The company faces ongoing financial challenges, including negative returns on equity and consecutive quarterly losses, while institutional investor participation has also decreased, indicating a tough market environment.
SINTX Technologies Forms Death Cross, Signaling Potential Bearish Trend Ahead
SINTX Technologies, Inc. has recently encountered a Death Cross, indicating a potential shift in market sentiment. The company has faced a challenging year, with a significant decline in its stock performance compared to the S&P 500. Technical indicators suggest a prevailing bearish outlook, warranting close monitoring of future developments.
Is SINTX Technologies, Inc. technically bullish or bearish?
As of September 4, 2025, SINTX Technologies, Inc. shows a bullish technical trend with strong weekly indicators, despite mixed monthly signals, and has outperformed the S&P 500 recently, although it has significantly underperformed over the past three years.
Is SINTX Technologies, Inc. overvalued or undervalued?
As of March 29, 2023, SINTX Technologies, Inc. is rated as risky due to overvaluation and poor financial metrics, including a negative P/E ratio of -1.6293, despite a recent strong 1-month return of 32.70%, which still underperformed compared to the S&P 500's 2.33% return.
Is SINTX Technologies, Inc. overvalued or undervalued?
As of March 29, 2023, SINTX Technologies, Inc. is classified as "risky" and overvalued, with poor financial metrics including a Price to Book Value of 1.17, a negative ROCE of -822.40%, and a one-year return of -45.66%, significantly underperforming the S&P 500.
Is SINTX Technologies, Inc. technically bullish or bearish?
As of June 10, 2025, SINTX Technologies, Inc. shows a neutral technical trend with mixed signals, indicating a shift from mildly bearish to sideways, as weekly indicators suggest mild bullishness while daily moving averages lean bearish.
Who are in the management team of SINTX Technologies, Inc.?
As of March 2022, the management team of SINTX Technologies, Inc. is led by Dr. B. Sonny Bal, who is the Chairman, President, CEO, and CFO, alongside independent directors Mr. Mark Froimson, Mr. Eric Stookey, Mr. David Truetzel, and Mr. Jeffrey White.
What does SINTX Technologies, Inc. do?
SINTX Technologies, Inc. is a biomaterial company specializing in silicon nitride orthopedic medical devices. As of March 2025, it reported net sales of $0 million and a net loss of $2 million, with a market cap of $8.38 million.
How big is SINTX Technologies, Inc.?
As of Jun 18, SINTX Technologies, Inc. has a market capitalization of 8.38 million, with net sales of 2.57 million and a net profit of -12.43 million over the latest four quarters. Shareholder's funds are 3.89 million, and total assets amount to 9.41 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
